Clinical trials: Congestive Heart Failure, completed
Sudden Cardiac Death, Sudden Cardiac Arrest
Heart Failure Optimization Study
This study is designed as a multi-center prospective observational study of newly diagnosed Heart Failure (HF) patients to test the hypothesis that additional Ejection Fraction (EF) recovery occurs between 90 and 180 days as…
- Conditions
- Sudden Cardiac Death, Sudden Cardiac Arrest, Heart Failure, Heart Failure Low Output
- Trial name
- HF-Opt (NCT03016754)
- Testing
- Wearable Cardioverter Defibrillator
- Where
- 67 sites in United States, Austria and 2 more
- Volunteers
- 602 people
- Sponsor
- Zoll Medical Corporation
COVID-19, Long COVID
Using Data From a Multisensor Rapid Health Assessment Device to Predict Decompensation in Long COVID (AIDI)
We are conducting a research study at the VA hospital in Bedford, MA to learn more about how a multisensor rapid health assessment device, MouthLab, can help predict or anticipate future health complications in patients with…
- Trial name
- AIDI (NCT05713266)
- Testing
- MouthLabTM
- Where
- United States
- Volunteers
- 204 people, healthy volunteers welcome
- Sponsor
- Edith Nourse Rogers Memorial Veterans Hospital
Heart Failure
Bioimpedance Spectroscopy for the Evaluation of Heart Failure
Despite impressive improvements in treatment strategies, heart failure (HF) morbidity and mortality remains substantially high worldwide.
- Trial name
- BIS-HF (NCT02764073)
- Testing
- Bioimpedance spectroscopy, Lung Ultrasonography, Echocardiography
- Where
- Romania
- Volunteers
- 150 people
- Sponsor
- Grigore T. Popa University of Medicine and Pharmacy
Heart Failure, Congestive
Health E Heart Study (South Texas Veterans Health Care System Heart Failure Disease Management Program/Study)
The primary objective of this telephonic heart failure specific patient education study is to assess the incremental clinical, psycho-social, and functional lifestyle benefits of the Health E Heart Study (South Texas Veterans…
- Trial name
- NCT00141856
- Testing
- Telephone care
- Where
- United States
- Volunteers
- 420 people
- Sponsor
- US Department of Veterans Affairs
Heart Failure, Congestive, Dilated Cardiomyopathy
Efficacy and Safety Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure
The study is divided into 2 parts. In the first part, the safety of the gene transfer agent MYDICAR® will be evaluated. In the second part, the ability of MYDICAR® to improve heart function will be studied.
- Trial name
- CUPID (NCT00454818)
- Testing
- MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)
- Where
- 22 sites in United States
- Volunteers
- 51 people
- Sponsor
- Celladon Corporation
Heart Failure
Detection of Phrenic Nerve Stimulation Using Sensors' Signals
The purpose of this study is to collect sensor data from patients with implanted cardiac resynchronization devices who exhibit phrenic nerve stimulation.
- Trial name
- DETECT PS (NCT01233323)
- Where
- Germany
- Volunteers
- 60 people
- Sponsor
- Boston Scientific Corporation
Aortic Stenosis, Heart Failure
High-Sensitivity Troponin T Plasma Levels in Patients With Aortic Stenosis (Tyrolean Aortic Stenosis Study-2)
TASS-2 (Tyrolean Aortic Stenosis Study-2) aims to characterize the clinical value of minimally elevated troponin T plasma levels both in patients with asymptomatic and symtomatic aortic stenosis.
- Conditions
- Aortic Stenosis, Heart Failure, Syncope, Angina Pectoris
- Trial name
- TASS-2 (NCT02448485)
- Testing
- Aortic Valve Intervention (surgical or transcatheter)
- Where
- Austria
- Volunteers
- 10,000 people
- Sponsor
- Medical University Innsbruck
Heart Failure NYHA Class IV, Heart Failure NYHA Class II
Impact of Sacubitril/Valsartan on Quality of Life and Mortality of CKD vs Non-CKD in Heart Failure Patients
The two primary goals of it's management are preventing further disease progression(mortality,hospitalizations and deterioration of left ventricular function)and alleviating patient suffering
- Trial name
- NCT04218435
- Testing
- Sacubitril / Valsartan Oral Tablet
- Where
- Pakistan
- Volunteers
- 200 people
- Sponsor
- Clinision
Heart Failure
Prospective Study of the BioVentrix PliCath HF™ System for the Treatment of Ischemic Cardiomyopathy
The purpose of the study is to determine the safety, and feasibility of a device, which enables LV volume and radius reduction through scar exclusion in patients whose systolic HF is due to ischemic cardiomyopathy.
- Trial name
- CONFIGURE-HF (NCT01568138)
- Testing
- PliCath HF System
- Where
- 4 sites in Latvia, Lithuania and 2 more
- Volunteers
- 26 people
- Sponsor
- BioVentrix
Cardiac Insufficiency
Effects of Left Ventricular Assist Device Implantation on the Phenotype of Blood Platelets and Leucocytes
To compare in vivo platelet and leukocyte activation and phenotype before and after Left ventricular assist device (LAVD) implantation
- Trial name
- DAV-Hémo (NCT03306017)
- Testing
- Blood sampling
- Where
- France
- Volunteers
- 4 people
- Sponsor
- University Hospital, Toulouse
Dyspnea; Cardiac
Bedside Lung Ultrasonography by Nurses in Acute Dyspnea.
This study assesses the potential of lung ultrasonography to diagnose heart failure.
- Trial name
- LUS (NCT05126940)
- Testing
- we perform a lung ultrasound to all the patients admitted for dyspnea independantly from the final diagnosis
- Where
- Tunisia
- Volunteers
- 216 people
- Sponsor
- University of Monastir
Heart Failure, Chronic Heart Failure
Continuum: Digital Health to Manage Heart Failure Outpatients
Heart failure (HF) is one of the leading causes of hospitalization and death worldwide. Remote patient monitoring and digital therapeutics could help reduce the consumption of care for these patients (hospitalizations, emergency…
- Trial name
- NCT05377190
- Testing
- Continuum HFC-IN, Standard of care for the follow-up, Continuum HFC-OUT
- Where
- Canada
- Volunteers
- 175 people
- Sponsor
- Centre hospitalier de l'Université de Montréal (CHUM)
Heart Failure
Quartet 1457Q Left Ventricular (LV) Lead Investigational Device Exemption (IDE) Study
The primary intent of this study is to assess the safety of the model 1457Q Quartet LV lead at 3 months in a patient population indicated for cardiac resynchronization therapy.
- Trial name
- NCT02548455
- Testing
- Quartet 1457Q LV Lead
- Where
- 30 sites in United States
- Volunteers
- 499 people
- Sponsor
- Abbott Medical Devices
Congestive Heart Failure, Diastole
Aldosterone Antagonism in Diastolic Heart Failure
The primary purpose of this study is to determine whether eplerenone has a beneficial effect on improving exercise ability in patients with diastolic heart failure.
- Trial name
- NCT00108251
- Testing
- Eplerenone
- Where
- United States
- Volunteers
- 48 people
- Sponsor
- US Department of Veterans Affairs
Heart Failure
Randomized Trial of Nordic Walking vs. Standard Cardiac Rehabilitation in Patients With Heart Failure
The main purpose of our project is to see if a 12-week program of Nordic walking is better than standard exercise therapy for increasing exercise capacity (measured by how far people can walk in 6 minutes) and increasing quality…
- Trial name
- NCT02061319
- Testing
- Nordic Walking
- Where
- Canada
- Volunteers
- 77 people
- Sponsor
- Ottawa Heart Institute Research Corporation
Cardio-renal Syndrome
Ultrafiltration Versus Medical Therapies in the Management of the Cardio Renal Syndrome
Type 2 cardio renal syndrome is defined by the occurrence or the exacerbation of a kidney failure induced by a chronic heart failure.
- Trial name
- UF-CARE (NCT02846337)
- Testing
- ULTRAFILTRATION, ENHANCED MEDICAL TREATMENT
- Where
- France
- Volunteers
- 108 people
- Sponsor
- Hospices Civils de Lyon
Tricuspid Regurgitation, Heart Failure
The Long-term Course of Moderate Tricuspid Regurgitation
To evaluate the long-term clinical outcome of a cohort of patients suffering from moderate tricuspid regurgitation (TR), regardless of its etiology.
- Conditions
- Tricuspid Regurgitation, Heart Failure, Echocardiography
- Trial name
- LOCOMOTRI (NCT06169345)
- Testing
- Echocardiographic evaluation
- Where
- Italy
- Volunteers
- 250 people
- Sponsor
- IRCCS San Raffaele
Heart Failure, High Blood Pressure
BVA-200 vs BVA-100 Validation Study
The proposed study is a prospective, observational, investigator and patient blinded study comparing the results of blood volume measurement using the FDA-cleared Daxor BVA-100 device to the Daxor BVA-200 device.
- Conditions
- Heart Failure, High Blood Pressure, High Cholesterol, Anemia
- Trial name
- NCT06227819
- Testing
- BVA-200
- Where
- United States
- Volunteers
- 62 people, healthy volunteers welcome
- Sponsor
- Daxor Corporation
Chronic Heart Failure, Cardiac Cachexia
Enteral Nutrition in Congestive Heart Failure and Cardiac Cachexia
The purpose of this study was to determine the effects of a high caloric drink on weight and several other clinical markers including quality of life in patients with unintentional weight loss (cachexia) due to chronic heart…
- Trial name
- NCT00654719
- Testing
- NutriDrink
- Where
- 2 sites in Germany, Poland
- Volunteers
- 29 people
- Sponsor
- National Heart and Lung Institute
Cardiogenic Shock, Acute Decompensated Heart Failure
SURPASS Impella 5.5 Study
A multi-center, prospective \& retrospective, observational single-arm study of the clinical outcomes up to one year collected from electronic health records of patients which have undergone standard of care implantation of…
- Trial name
- NCT05100836
- Testing
- Impella 5.5
- Where
- 15 sites in United States
- Volunteers
- 1,017 people
- Sponsor
- Abiomed Inc.
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.